Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 1/20 | 0.41 |
| ▸ | TDO2 | P48775 | 1/20 | 0.41 |
| ▸ | KIF11 | P52732 | 2/20 | 0.38 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.38 |
| ▸ | BCHE | P06276 | 1/20 | 0.37 |
| ▸ | ACHE | P22303 | 1/20 | 0.37 |
| ▸ | BACE1 | P56817 | 1/20 | 0.37 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.37 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.37 |
| ▸ | BCL9 | O00512 | 1/20 | 0.36 |
| ▸ | CTNNB1 | P35222 | 1/20 | 0.36 |
| ▸ | CXCL12 | P48061 | 1/20 | 0.36 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.36 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.36 |
| ▸ | KDR | P35968 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8530835 | 0.90 | FGFR2 (0.40) | TDO2CYP3A4MAPTRAB9AALOX15 | |
| SCHEMBL1009822 | 0.84 | SLC2A1 (0.39) | IDO1TDO2CXCL12KDRCYP3A4 | |
| SCHEMBL6823069 | 0.84 | PDE4B (0.41) | KDRCYP3A4KDM4ECYP2D6CYP2C9 | |
| SCHEMBL22149138 | 0.78 | CFTR (0.45) | IDO1TDO2KIF11AKR1C3AKR1C2 | |
| SCHEMBL27788098 | 0.76 | ALOX15 (0.41) | CYP3A4KDM4ECYP1A2MAPTALOX15 | |
| SCHEMBL3947944 | 0.72 | CSNK2A2 (0.39) | KDM4EMAPTRAB9ALMNATP53 | |
| SCHEMBL175821 | 0.72 | MCHR1 (0.40) | MCHR1CYP3A4CYP1A2CYP2D6CYP2C19 | |
| SCHEMBL1816876 | 0.72 | IDO1 (0.39) | IDO1TDO2KIF11MCHR1BCHE | |
| SCHEMBL9898544 | 0.70 | KCNA5 (0.41) | BACE1CYP3A4KDM4ECYP1A2CYP2D6 | |
| SCHEMBL14762327 | 0.69 | S1PR1 (0.39) | MCHR1AKR1C3AKR1C2MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2078006-B1 | PHOTOCHROMIC MATERIALS DEMONSTRATING IMPROVED FADE RATES | TRANSITIONS OPTICAL INC (US) | 2018-11-07 | — | — | EP | disclosed |
| US-9006427-B2 | Photochromic materials demonstrating improved fade rates | TRANSITIONS OPTICAL, INC. (US) | 2015-04-14 | — | — | US | disclosed |
| US-8748634-B2 | Photochromic materials demonstrating improved fade rates | TRANSITIONS OPTICAL, INC. (US) | 2014-06-10 | — | — | US | disclosed |
| US-20140155598-A1 | PHOTOCHROMIC MATERIALS DEMONSTRATING IMPROVED FADE RATES | TRANSITIONS OPTICAL, INC. (US) | 2014-06-05 | — | — | US | disclosed |
| EP-2078006-A2 | PHOTOCHROMIC MATERIALS DEMONSTRATING IMPROVED FADE RATES | TRANSITIONS OPTICAL, INC. (US) | 2009-07-15 | — | — | EP | disclosed |
| WO-2008054942-A2 | PHOTOCHROMIC MATERIALS DEMONSTRATING IMPROVED FADE RATES | TRANSITIONS OPTICAL, INC. (US) | 2008-05-08 | — | — | WO | disclosed |
| US-20080103301-A1 | PHOTOCHROMIC MATERIALS DEMONSTRATING IMPROVED FADE RATES | TRANSITIONS OPTICAL, INC. (US) | 2008-05-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080103301-A1 | PHOTOCHROMIC MATERIALS DEMONSTRATING IMPROVED FADE RATES | PNPO, FLAD1, CRY2 | IDO1 75/4885TDO2 17/4885KIF11 2984/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.